BioengineeringbioRxivPreprint
Enhanced anti-tumor effects through continuous administration of engineered CAR-macrophages derived from pluripotent stem cell-derived myeloid celllines.
Yuya Atsumi, Akira Niwa, Tatsuro Kumaki…·Megumu K. Saito
This study develops CAR-macrophages from pluripotent stem cell-derived myeloid cell lines for enhanced anti-tumor effects through repeated administration.
DOI 10.1101/2024.07.22.604686